Client News

Roquefort Therapeutics plc: Resignation of Auditor
Home / Client News / Roquefort Therapeutics plc: Resignation of Auditor

Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, announces that Jeffreys Henry LLP have notified the Company of their resignation of auditor of the Company.



If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This